Abstract:Ginsenoside bioactive compounds, namely, compound K (C-K), compound Mx (C-Mx), and ginsenoside Mc (G-Mc), were the metabolites of ginsenosides Rb-l, Rb-2, Rb-3, and R-c by intestinal microflora of humans or rats, microorganisms, and enzymes, and C-K showed beneficial effects in vitro and in vivo as an antitumoral agent. The objective of this work was to explore an efficient procedure for biotransformation of these bioactive compounds. Thus, a filamentous fungus, Fusarium sacchari, was first obtained from the soil-cultivated ginseng, which was verified to possess a potent capacity of transformation of C-K, C-Mx, and G-Mc. The optimal biotransformation conditions of F sacchari with C-K, C-Mx, and G-Mc were obtained as follows: transforming temperature, 30 degrees C; transforming time, 6 days; rotary speed, 160 rpm; pH of the medium, 5.5. HPLC analysis indicated that these three bioactive compounds were key metabolites and their structures were confirmed by H-1 and C-13 NMR analysis. Moreover, the in vitro antitumor activities of C-K, C-Mx, and G-Mc and the in vivo antitumor activities of the transformed product mainly containing these compounds were also evaluated. Among C-K, C-Mx, and G-Mc, C-K exhibited the most potent antitumor activities. The in vivo study showed that the transformed products by F sacchari had much more antitumor activity than those of commonly used ginsenoside Rg(3) and Paclitaxel.

Screening, Identification and Transformational Property of Minor Ginsenoside Compound K-Producing Fungus

Production of bioactive ginsenoside Rg3(S) and compound K using recombinant Lactococcus lactis .

Transformation of Bioactive Compounds by Fusarium Sacchari Fungus Isolated from the Soil-Cultivated Ginseng

Isolation of high-conversion ginsenoside strain and optimization of fermentation medium

Biotransformation of Major Ginsenosides into Compound K by a New Penicillium Dipodomyicola Strain Isolated from the Soil of Wild Ginseng

Biotransformation Pathways of Ginsenoside Rb1 to Compound K by Β-Glucosidases in Fungus Paecilomyces Bainier Sp. 229

Highly Selective Bioconversion of Ginsenoside Rb1 to Compound K by the Mycelium of Cordyceps sinensis under Optimized Conditions

Co-transformation of Panax Major Ginsenosides Rb1 and Rg1 to Minor Ginsenosides C–K and F1 by Cladosporium Cladosporioides

Purification and characterization of two novel β-glucosidases from Penicillium oxalicum and their application in bioactive ginsenoside production

Screening and Identification of Microorganisms for the Biotransformation of Rare Ginsenosides

Bioconversion of Ginsenoside Rb1 to Compound K Using Leuconostoc Lactis DC201

Study on biotransformation of ginseng root saponins to minor ginsenosides F2 and C-K by endophyte from Codonopsis pilosula

Biotransformation of ginsenosides by glycoside hydrolase from an endophytic fungus of Panax ginseng

Enzymatic biotransformation of ginsenoside Rb1 to compound K by recombinant β-glucosidase from Microbacterium esteraromaticum.

Microbiological Transformation of Ginsenoside Rb1 into C-K

Microbial Transformation of Ginsenoside Rb1 by Rhizopus Stolonifer and Curvularia Lunata

Biotransformation of Ginsenoside Rb1 to Ginsenoside C-K by Endophytic Fungus Arthrinium Sp Ge 17-18 Isolated from Panax Ginseng

Biotransformation of High Concentrations of Ginsenoside Substrate into Compound K by Β-Glycosidase from Sulfolobus Solfataricus.

Bioconversion of Ginsenoside Rb1 into Compound K by Leuconostoc Citreum Lh1 Isolated from Kimchi

Biotransformation of Ginsenoside Rb1 to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F2, and Compound K by Leuconostoc mesenteroides DC102.

Enzymatic transformation of ginsenoside Rg3 to Rh2 using newly isolated Fusarium proliferatum ECU2042